Lilly’s Direct-to-Consumer GLP-1 Service Likely Doesn’t Threaten PBMs

Pharmacy benefit experts say that the move is sure to improve market access for Lilly’s weight loss drugs, but they also say that the impact of the new service on PBMs is likely to be minimal.